Yoga as a Supportive Therapy for Patients With Hypertension

May 2, 2017 updated by: Holger Cramer, Universität Duisburg-Essen

Yoga as a Supportive Therapy for Patients With Hypertension: A Randomized Controlled Trial

The proposed study aims to investigate the feasibility, effectiveness, and perceived benefit of a supportive hatha yoga intervention for patients with hypertension using antihypertensive drugs. Patients will be randomized into 3 groups comparing hatha yoga with yoga postures, breathing and relaxation techniques to a hatha yoga intervention without yoga postures (only breathing and relaxation techniques) as well as to a wait list control group.

Study Overview

Study Type

Interventional

Enrollment (Actual)

75

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Essen, Germany
        • Department of Internal and Integrative Medicine, Kliniken Essen-Mitte

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 75 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • essential Hypertension
  • stable antihypertensive medication during the next 6 months

Exclusion Criteria:

  • pregnancy or breast feeding
  • simultaneous participation in further clinical intervention trials
  • regular yoga practice in the past 12 months
  • serious mental illness (severe depression, severe addiction, psychosis)
  • manifest coronary heart disease that has been treated in the past 3 months or myocardial infarction, embolism of pulmonary arteries or stroke in the past 3 months
  • heart failure ≥ state 1 New York Heart Association (NYHA)
  • peripheral arterial occlusive disease ≥ state 1
  • renal insufficiency > state 2, glomerular filtration rate < 60 ml/min/1,73m² according to he National Kidney Foundation (NKF)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Wait-list control group
Experimental: Yoga with Asana (yoga postures)
Yoga intervention consisting of asana, breathing and relaxation, meditation
Experimental: Yoga without Asana (yoga postures)
Yoga intervention without asanas, consisting only of breathing, relaxation and meditation

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
24 h mean value of systolic and diastolic blood pressure
Time Frame: 12 weeks
12 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Adverse Events
Time Frame: 12 weeks
12 weeks
24 h mean value of systolic and diastolic blood pressure
Time Frame: 28 weeks
28 weeks
Health-related Quality of Life
Time Frame: 12 weeks
Short Form 36 Health Survey Questionnaire (SF-36)
12 weeks
Health-related Quality of Life
Time Frame: 28 weeks
Short Form 36 Health Survey Questionnaire (SF-36)
28 weeks
Emotional Distress
Time Frame: 12 weeks
Hospital Anxiety and Depression Scale (HADS)
12 weeks
Emotional Distress
Time Frame: 28 weeks
Hospital Anxiety and Depression Scale (HADS)
28 weeks
Subjective Stress
Time Frame: 12 weeks
Cohen Perceived Stress Scale (CPSS)
12 weeks
Subjective Stress
Time Frame: 28 weeks
Cohen Perceived Stress Scale (CPSS)
28 weeks
Nutrition habits
Time Frame: 12 weeks
Five a Day Food Frequency Questionnaire
12 weeks
Nutrition habits
Time Frame: 28 weeks
Five a Day Food Frequency Questionnaire
28 weeks
Physical activity
Time Frame: 12 weeks
Baecke Physical Activity Questionnaire
12 weeks
Physical activity
Time Frame: 28 weeks
Baecke Physical Activity Questionnaire
28 weeks
Adverse Events
Time Frame: 28 weeks
28 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 1, 2016

Primary Completion (Actual)

January 1, 2017

Study Completion (Actual)

April 1, 2017

Study Registration Dates

First Submitted

March 23, 2016

First Submitted That Met QC Criteria

April 1, 2016

First Posted (Estimate)

April 4, 2016

Study Record Updates

Last Update Posted (Actual)

May 3, 2017

Last Update Submitted That Met QC Criteria

May 2, 2017

Last Verified

May 1, 2017

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 15-6726-BO

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hypertension

Clinical Trials on Yoga with Asana (yoga postures)

Subscribe